nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCG2—Tamoxifen—pancreatic cancer	0.0772	0.13	CbGbCtD
Sumatriptan—SLCO1B1—Irinotecan—pancreatic cancer	0.0746	0.126	CbGbCtD
Sumatriptan—ABCG2—Erlotinib—pancreatic cancer	0.0657	0.111	CbGbCtD
Sumatriptan—ABCG2—Irinotecan—pancreatic cancer	0.0593	0.1	CbGbCtD
Sumatriptan—ABCG2—Fluorouracil—pancreatic cancer	0.0569	0.096	CbGbCtD
Sumatriptan—ABCG2—Docetaxel—pancreatic cancer	0.0434	0.0733	CbGbCtD
Sumatriptan—ABCG2—Sunitinib—pancreatic cancer	0.0433	0.073	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—pancreatic cancer	0.0324	0.0547	CbGbCtD
Sumatriptan—ABCB1—Tamoxifen—pancreatic cancer	0.0278	0.047	CbGbCtD
Sumatriptan—ABCB1—Gemcitabine—pancreatic cancer	0.024	0.0405	CbGbCtD
Sumatriptan—ABCB1—Erlotinib—pancreatic cancer	0.0237	0.0399	CbGbCtD
Sumatriptan—ABCB1—Irinotecan—pancreatic cancer	0.0214	0.0361	CbGbCtD
Sumatriptan—HTR3A—enteric nervous system—pancreatic cancer	0.0162	0.69	CbGeAlD
Sumatriptan—ABCB1—Docetaxel—pancreatic cancer	0.0157	0.0264	CbGbCtD
Sumatriptan—ABCB1—Sunitinib—pancreatic cancer	0.0156	0.0263	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—pancreatic cancer	0.0117	0.0197	CbGbCtD
Sumatriptan—HTR3A—islet of Langerhans—pancreatic cancer	0.00155	0.066	CbGeAlD
Sumatriptan—MAOA—islet of Langerhans—pancreatic cancer	0.00096	0.0408	CbGeAlD
Sumatriptan—HTR3A—digestive system—pancreatic cancer	0.000932	0.0396	CbGeAlD
Sumatriptan—SLCO1B1—digestive system—pancreatic cancer	0.000904	0.0384	CbGeAlD
Sumatriptan—SLCO1A2—digestive system—pancreatic cancer	0.000736	0.0313	CbGeAlD
Sumatriptan—MAOA—pancreas—pancreatic cancer	0.000675	0.0287	CbGeAlD
Sumatriptan—MAOA—digestive system—pancreatic cancer	0.000576	0.0245	CbGeAlD
Sumatriptan—ABCB1—islet of Langerhans—pancreatic cancer	0.00041	0.0174	CbGeAlD
Sumatriptan—ABCB1—pancreas—pancreatic cancer	0.000289	0.0123	CbGeAlD
Sumatriptan—ABCB1—digestive system—pancreatic cancer	0.000246	0.0105	CbGeAlD
Sumatriptan—Body temperature increased—Gemcitabine—pancreatic cancer	0.000122	0.000426	CcSEcCtD
Sumatriptan—Dysuria—Epirubicin—pancreatic cancer	0.000121	0.000424	CcSEcCtD
Sumatriptan—Rash—Sunitinib—pancreatic cancer	0.000121	0.000423	CcSEcCtD
Sumatriptan—Dermatitis—Sunitinib—pancreatic cancer	0.000121	0.000423	CcSEcCtD
Sumatriptan—Abdominal distension—Doxorubicin—pancreatic cancer	0.000121	0.000423	CcSEcCtD
Sumatriptan—Urticaria—Fluorouracil—pancreatic cancer	0.00012	0.000421	CcSEcCtD
Sumatriptan—Headache—Sunitinib—pancreatic cancer	0.00012	0.000421	CcSEcCtD
Sumatriptan—Syncope—Docetaxel—pancreatic cancer	0.00012	0.00042	CcSEcCtD
Sumatriptan—Dysphagia—Doxorubicin—pancreatic cancer	0.00012	0.00042	CcSEcCtD
Sumatriptan—Asthma—Doxorubicin—pancreatic cancer	0.00012	0.00042	CcSEcCtD
Sumatriptan—Influenza—Doxorubicin—pancreatic cancer	0.00012	0.00042	CcSEcCtD
Sumatriptan—Pollakiuria—Epirubicin—pancreatic cancer	0.00012	0.000419	CcSEcCtD
Sumatriptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.00012	0.000419	CcSEcCtD
Sumatriptan—Palpitations—Docetaxel—pancreatic cancer	0.000118	0.000414	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000118	0.000414	CcSEcCtD
Sumatriptan—Weight increased—Epirubicin—pancreatic cancer	0.000118	0.000413	CcSEcCtD
Sumatriptan—Loss of consciousness—Docetaxel—pancreatic cancer	0.000118	0.000412	CcSEcCtD
Sumatriptan—Pancreatitis—Doxorubicin—pancreatic cancer	0.000117	0.000412	CcSEcCtD
Sumatriptan—Weight decreased—Epirubicin—pancreatic cancer	0.000117	0.00041	CcSEcCtD
Sumatriptan—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000117	0.000409	CcSEcCtD
Sumatriptan—Cough—Docetaxel—pancreatic cancer	0.000117	0.000409	CcSEcCtD
Sumatriptan—Angina pectoris—Doxorubicin—pancreatic cancer	0.000117	0.000409	CcSEcCtD
Sumatriptan—Hypersensitivity—Irinotecan—pancreatic cancer	0.000116	0.000408	CcSEcCtD
Sumatriptan—Convulsion—Docetaxel—pancreatic cancer	0.000116	0.000406	CcSEcCtD
Sumatriptan—Hypertension—Docetaxel—pancreatic cancer	0.000115	0.000405	CcSEcCtD
Sumatriptan—Drowsiness—Epirubicin—pancreatic cancer	0.000115	0.000404	CcSEcCtD
Sumatriptan—Bronchitis—Doxorubicin—pancreatic cancer	0.000115	0.000404	CcSEcCtD
Sumatriptan—Arthralgia—Docetaxel—pancreatic cancer	0.000114	0.000399	CcSEcCtD
Sumatriptan—Myalgia—Docetaxel—pancreatic cancer	0.000114	0.000399	CcSEcCtD
Sumatriptan—Chest pain—Docetaxel—pancreatic cancer	0.000114	0.000399	CcSEcCtD
Sumatriptan—Nausea—Sunitinib—pancreatic cancer	0.000114	0.000399	CcSEcCtD
Sumatriptan—Pancytopenia—Doxorubicin—pancreatic cancer	0.000114	0.000399	CcSEcCtD
Sumatriptan—Asthenia—Irinotecan—pancreatic cancer	0.000113	0.000397	CcSEcCtD
Sumatriptan—Conjunctivitis—Epirubicin—pancreatic cancer	0.000112	0.000393	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—pancreatic cancer	0.000112	0.000392	CcSEcCtD
Sumatriptan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000111	0.00039	CcSEcCtD
Sumatriptan—Dry mouth—Docetaxel—pancreatic cancer	0.000111	0.00039	CcSEcCtD
Sumatriptan—Sweating—Epirubicin—pancreatic cancer	0.000111	0.000388	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—pancreatic cancer	0.000111	0.000388	CcSEcCtD
Sumatriptan—Asthenia—Gemcitabine—pancreatic cancer	0.00011	0.000387	CcSEcCtD
Sumatriptan—Haematuria—Epirubicin—pancreatic cancer	0.00011	0.000386	CcSEcCtD
Sumatriptan—Confusional state—Docetaxel—pancreatic cancer	0.00011	0.000386	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000109	0.000383	CcSEcCtD
Sumatriptan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000109	0.000382	CcSEcCtD
Sumatriptan—Oedema—Docetaxel—pancreatic cancer	0.000109	0.000382	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—pancreatic cancer	0.000109	0.000382	CcSEcCtD
Sumatriptan—Epistaxis—Epirubicin—pancreatic cancer	0.000109	0.000382	CcSEcCtD
Sumatriptan—Pruritus—Gemcitabine—pancreatic cancer	0.000109	0.000381	CcSEcCtD
Sumatriptan—Infection—Docetaxel—pancreatic cancer	0.000108	0.00038	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—pancreatic cancer	0.000108	0.00038	CcSEcCtD
Sumatriptan—Sinusitis—Epirubicin—pancreatic cancer	0.000108	0.000379	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000108	0.000379	CcSEcCtD
Sumatriptan—Diarrhoea—Irinotecan—pancreatic cancer	0.000108	0.000379	CcSEcCtD
Sumatriptan—Shock—Docetaxel—pancreatic cancer	0.000107	0.000376	CcSEcCtD
Sumatriptan—Nervous system disorder—Docetaxel—pancreatic cancer	0.000107	0.000375	CcSEcCtD
Sumatriptan—Pruritus—Fluorouracil—pancreatic cancer	0.000107	0.000375	CcSEcCtD
Sumatriptan—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000107	0.000374	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—pancreatic cancer	0.000107	0.000374	CcSEcCtD
Sumatriptan—Tachycardia—Docetaxel—pancreatic cancer	0.000107	0.000373	CcSEcCtD
Sumatriptan—Skin disorder—Docetaxel—pancreatic cancer	0.000106	0.000371	CcSEcCtD
Sumatriptan—Bradycardia—Epirubicin—pancreatic cancer	0.000106	0.00037	CcSEcCtD
Sumatriptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000105	0.000369	CcSEcCtD
Sumatriptan—Dizziness—Irinotecan—pancreatic cancer	0.000104	0.000366	CcSEcCtD
Sumatriptan—Haemoglobin—Epirubicin—pancreatic cancer	0.000104	0.000365	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000104	0.000364	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—pancreatic cancer	0.000104	0.000363	CcSEcCtD
Sumatriptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000103	0.000363	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000103	0.000361	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—pancreatic cancer	0.000102	0.000359	CcSEcCtD
Sumatriptan—Hypotension—Docetaxel—pancreatic cancer	0.000102	0.000357	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—pancreatic cancer	0.000102	0.000357	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000102	0.000357	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—pancreatic cancer	0.000101	0.000353	CcSEcCtD
Sumatriptan—Vomiting—Irinotecan—pancreatic cancer	0.0001	0.000352	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—pancreatic cancer	0.0001	0.000351	CcSEcCtD
Sumatriptan—Dizziness—Fluorouracil—pancreatic cancer	0.0001	0.00035	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—pancreatic cancer	9.99e-05	0.00035	CcSEcCtD
Sumatriptan—Rash—Irinotecan—pancreatic cancer	9.96e-05	0.000349	CcSEcCtD
Sumatriptan—Dermatitis—Irinotecan—pancreatic cancer	9.95e-05	0.000349	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.95e-05	0.000348	CcSEcCtD
Sumatriptan—Headache—Irinotecan—pancreatic cancer	9.89e-05	0.000347	CcSEcCtD
Sumatriptan—Paraesthesia—Docetaxel—pancreatic cancer	9.8e-05	0.000343	CcSEcCtD
Sumatriptan—Vomiting—Gemcitabine—pancreatic cancer	9.78e-05	0.000343	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—pancreatic cancer	9.76e-05	0.000342	CcSEcCtD
Sumatriptan—Dyspnoea—Docetaxel—pancreatic cancer	9.73e-05	0.000341	CcSEcCtD
Sumatriptan—Somnolence—Docetaxel—pancreatic cancer	9.71e-05	0.00034	CcSEcCtD
Sumatriptan—Rash—Gemcitabine—pancreatic cancer	9.7e-05	0.00034	CcSEcCtD
Sumatriptan—Dermatitis—Gemcitabine—pancreatic cancer	9.69e-05	0.000339	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—pancreatic cancer	9.69e-05	0.000339	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—pancreatic cancer	9.66e-05	0.000339	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—pancreatic cancer	9.64e-05	0.000338	CcSEcCtD
Sumatriptan—Headache—Gemcitabine—pancreatic cancer	9.64e-05	0.000338	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—pancreatic cancer	9.62e-05	0.000337	CcSEcCtD
Sumatriptan—Vomiting—Fluorouracil—pancreatic cancer	9.62e-05	0.000337	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—pancreatic cancer	9.59e-05	0.000336	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.54e-05	0.000334	CcSEcCtD
Sumatriptan—Rash—Fluorouracil—pancreatic cancer	9.54e-05	0.000334	CcSEcCtD
Sumatriptan—Dermatitis—Fluorouracil—pancreatic cancer	9.53e-05	0.000334	CcSEcCtD
Sumatriptan—Decreased appetite—Docetaxel—pancreatic cancer	9.49e-05	0.000332	CcSEcCtD
Sumatriptan—Headache—Fluorouracil—pancreatic cancer	9.48e-05	0.000332	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.43e-05	0.00033	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—pancreatic cancer	9.42e-05	0.00033	CcSEcCtD
Sumatriptan—Fatigue—Docetaxel—pancreatic cancer	9.41e-05	0.00033	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—pancreatic cancer	9.4e-05	0.000329	CcSEcCtD
Sumatriptan—Nausea—Irinotecan—pancreatic cancer	9.38e-05	0.000329	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—pancreatic cancer	9.36e-05	0.000328	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—pancreatic cancer	9.34e-05	0.000327	CcSEcCtD
Sumatriptan—Pain—Docetaxel—pancreatic cancer	9.34e-05	0.000327	CcSEcCtD
Sumatriptan—Constipation—Docetaxel—pancreatic cancer	9.34e-05	0.000327	CcSEcCtD
Sumatriptan—Chills—Epirubicin—pancreatic cancer	9.3e-05	0.000326	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—pancreatic cancer	9.26e-05	0.000324	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—pancreatic cancer	9.24e-05	0.000324	CcSEcCtD
Sumatriptan—Nausea—Gemcitabine—pancreatic cancer	9.14e-05	0.00032	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—pancreatic cancer	9.02e-05	0.000316	CcSEcCtD
Sumatriptan—Feeling abnormal—Docetaxel—pancreatic cancer	9e-05	0.000315	CcSEcCtD
Sumatriptan—Nausea—Fluorouracil—pancreatic cancer	8.98e-05	0.000315	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—pancreatic cancer	8.96e-05	0.000314	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—pancreatic cancer	8.94e-05	0.000313	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.93e-05	0.000313	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—pancreatic cancer	8.9e-05	0.000312	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—pancreatic cancer	8.89e-05	0.000311	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—pancreatic cancer	8.84e-05	0.00031	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—pancreatic cancer	8.73e-05	0.000306	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—pancreatic cancer	8.7e-05	0.000305	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—pancreatic cancer	8.67e-05	0.000304	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—pancreatic cancer	8.66e-05	0.000303	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—pancreatic cancer	8.64e-05	0.000303	CcSEcCtD
Sumatriptan—Abdominal pain—Docetaxel—pancreatic cancer	8.63e-05	0.000302	CcSEcCtD
Sumatriptan—Body temperature increased—Docetaxel—pancreatic cancer	8.63e-05	0.000302	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—pancreatic cancer	8.6e-05	0.000301	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—pancreatic cancer	8.57e-05	0.0003	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—pancreatic cancer	8.37e-05	0.000293	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—pancreatic cancer	8.35e-05	0.000292	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—pancreatic cancer	8.34e-05	0.000292	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—pancreatic cancer	8.29e-05	0.00029	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—pancreatic cancer	8.23e-05	0.000288	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—pancreatic cancer	8.18e-05	0.000286	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—pancreatic cancer	8.14e-05	0.000285	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—pancreatic cancer	8.11e-05	0.000284	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—pancreatic cancer	8.09e-05	0.000283	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—pancreatic cancer	8.08e-05	0.000283	CcSEcCtD
Sumatriptan—Hypersensitivity—Docetaxel—pancreatic cancer	8.04e-05	0.000282	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—pancreatic cancer	8.03e-05	0.000281	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—pancreatic cancer	7.97e-05	0.000279	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—pancreatic cancer	7.93e-05	0.000278	CcSEcCtD
Sumatriptan—Cough—Epirubicin—pancreatic cancer	7.87e-05	0.000276	CcSEcCtD
Sumatriptan—Asthenia—Docetaxel—pancreatic cancer	7.83e-05	0.000274	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—pancreatic cancer	7.82e-05	0.000274	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—pancreatic cancer	7.79e-05	0.000273	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.75e-05	0.000271	CcSEcCtD
Sumatriptan—Pruritus—Docetaxel—pancreatic cancer	7.72e-05	0.000271	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—pancreatic cancer	7.72e-05	0.00027	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—pancreatic cancer	7.68e-05	0.000269	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—pancreatic cancer	7.68e-05	0.000269	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—pancreatic cancer	7.68e-05	0.000269	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—pancreatic cancer	7.67e-05	0.000269	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—pancreatic cancer	7.65e-05	0.000268	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—pancreatic cancer	7.59e-05	0.000266	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—pancreatic cancer	7.53e-05	0.000264	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—pancreatic cancer	7.51e-05	0.000263	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—pancreatic cancer	7.5e-05	0.000263	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—pancreatic cancer	7.49e-05	0.000262	CcSEcCtD
Sumatriptan—Diarrhoea—Docetaxel—pancreatic cancer	7.47e-05	0.000262	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—pancreatic cancer	7.42e-05	0.00026	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—pancreatic cancer	7.38e-05	0.000258	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—pancreatic cancer	7.36e-05	0.000258	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—pancreatic cancer	7.36e-05	0.000258	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—pancreatic cancer	7.34e-05	0.000257	CcSEcCtD
Sumatriptan—Infection—Epirubicin—pancreatic cancer	7.32e-05	0.000256	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—pancreatic cancer	7.28e-05	0.000255	CcSEcCtD
Sumatriptan—Shock—Epirubicin—pancreatic cancer	7.24e-05	0.000254	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—pancreatic cancer	7.23e-05	0.000253	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—pancreatic cancer	7.22e-05	0.000253	CcSEcCtD
Sumatriptan—Dizziness—Docetaxel—pancreatic cancer	7.22e-05	0.000253	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—pancreatic cancer	7.21e-05	0.000253	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—pancreatic cancer	7.21e-05	0.000253	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—pancreatic cancer	7.19e-05	0.000252	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—pancreatic cancer	7.15e-05	0.000251	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—pancreatic cancer	7.12e-05	0.000249	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—pancreatic cancer	7.11e-05	0.000249	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—pancreatic cancer	7.11e-05	0.000249	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—pancreatic cancer	7.11e-05	0.000249	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—pancreatic cancer	7.08e-05	0.000248	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—pancreatic cancer	7.02e-05	0.000246	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—pancreatic cancer	6.95e-05	0.000244	CcSEcCtD
Sumatriptan—Vomiting—Docetaxel—pancreatic cancer	6.94e-05	0.000243	CcSEcCtD
Sumatriptan—Rash—Docetaxel—pancreatic cancer	6.88e-05	0.000241	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—pancreatic cancer	6.88e-05	0.000241	CcSEcCtD
Sumatriptan—Dermatitis—Docetaxel—pancreatic cancer	6.88e-05	0.000241	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—pancreatic cancer	6.87e-05	0.000241	CcSEcCtD
Sumatriptan—Headache—Docetaxel—pancreatic cancer	6.84e-05	0.00024	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.81e-05	0.000239	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—pancreatic cancer	6.81e-05	0.000239	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—pancreatic cancer	6.77e-05	0.000237	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.71e-05	0.000235	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—pancreatic cancer	6.7e-05	0.000235	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—pancreatic cancer	6.68e-05	0.000234	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.67e-05	0.000234	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—pancreatic cancer	6.65e-05	0.000233	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—pancreatic cancer	6.62e-05	0.000232	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—pancreatic cancer	6.61e-05	0.000232	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.59e-05	0.000231	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—pancreatic cancer	6.56e-05	0.00023	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—pancreatic cancer	6.55e-05	0.000229	CcSEcCtD
Sumatriptan—Nausea—Docetaxel—pancreatic cancer	6.48e-05	0.000227	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—pancreatic cancer	6.4e-05	0.000224	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—pancreatic cancer	6.37e-05	0.000223	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.36e-05	0.000223	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—pancreatic cancer	6.35e-05	0.000222	CcSEcCtD
Sumatriptan—Pain—Epirubicin—pancreatic cancer	6.3e-05	0.000221	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—pancreatic cancer	6.3e-05	0.000221	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.21e-05	0.000217	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—pancreatic cancer	6.12e-05	0.000214	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—pancreatic cancer	6.07e-05	0.000213	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—pancreatic cancer	6.07e-05	0.000213	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—pancreatic cancer	6.06e-05	0.000212	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.02e-05	0.000211	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—pancreatic cancer	5.92e-05	0.000207	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.88e-05	0.000206	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—pancreatic cancer	5.87e-05	0.000206	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—pancreatic cancer	5.85e-05	0.000205	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—pancreatic cancer	5.83e-05	0.000204	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—pancreatic cancer	5.83e-05	0.000204	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—pancreatic cancer	5.82e-05	0.000204	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—pancreatic cancer	5.82e-05	0.000204	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—pancreatic cancer	5.61e-05	0.000197	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.57e-05	0.000195	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—pancreatic cancer	5.43e-05	0.00019	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—pancreatic cancer	5.41e-05	0.00019	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—pancreatic cancer	5.39e-05	0.000189	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—pancreatic cancer	5.39e-05	0.000189	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—pancreatic cancer	5.28e-05	0.000185	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—pancreatic cancer	5.21e-05	0.000183	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—pancreatic cancer	5.04e-05	0.000177	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—pancreatic cancer	5.02e-05	0.000176	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—pancreatic cancer	4.89e-05	0.000171	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—pancreatic cancer	4.87e-05	0.000171	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—pancreatic cancer	4.82e-05	0.000169	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—pancreatic cancer	4.68e-05	0.000164	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—pancreatic cancer	4.66e-05	0.000163	CcSEcCtD
Sumatriptan—Rash—Epirubicin—pancreatic cancer	4.64e-05	0.000163	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—pancreatic cancer	4.64e-05	0.000163	CcSEcCtD
Sumatriptan—Headache—Epirubicin—pancreatic cancer	4.61e-05	0.000162	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—pancreatic cancer	4.51e-05	0.000158	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—pancreatic cancer	4.37e-05	0.000153	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—pancreatic cancer	4.33e-05	0.000152	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—pancreatic cancer	4.3e-05	0.00015	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—pancreatic cancer	4.29e-05	0.00015	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—pancreatic cancer	4.27e-05	0.00015	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—pancreatic cancer	4.05e-05	0.000142	CcSEcCtD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.86e-05	0.000189	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JAG1—pancreatic cancer	1.85e-05	0.000188	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOTCH3—pancreatic cancer	1.85e-05	0.000188	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	1.83e-05	0.000186	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CB—pancreatic cancer	1.83e-05	0.000186	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.82e-05	0.000185	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TERT—pancreatic cancer	1.82e-05	0.000185	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STK11—pancreatic cancer	1.81e-05	0.000184	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.8e-05	0.000183	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.8e-05	0.000183	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—pancreatic cancer	1.78e-05	0.000181	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TERT—pancreatic cancer	1.78e-05	0.000181	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DPYD—pancreatic cancer	1.77e-05	0.00018	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL8—pancreatic cancer	1.76e-05	0.000179	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HRAS—pancreatic cancer	1.75e-05	0.000178	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CNR1—pancreatic cancer	1.75e-05	0.000178	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HIF1A—pancreatic cancer	1.74e-05	0.000176	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.73e-05	0.000176	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSC2—pancreatic cancer	1.73e-05	0.000176	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—AKT1—pancreatic cancer	1.7e-05	0.000173	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HIF1A—pancreatic cancer	1.7e-05	0.000173	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.7e-05	0.000173	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSC2—pancreatic cancer	1.7e-05	0.000172	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.7e-05	0.000172	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—pancreatic cancer	1.7e-05	0.000172	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GCG—pancreatic cancer	1.69e-05	0.000172	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP3—pancreatic cancer	1.69e-05	0.000171	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.68e-05	0.000171	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.67e-05	0.00017	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KDR—pancreatic cancer	1.66e-05	0.000169	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—pancreatic cancer	1.66e-05	0.000169	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.64e-05	0.000167	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.64e-05	0.000167	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCND1—pancreatic cancer	1.64e-05	0.000167	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.63e-05	0.000166	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KDR—pancreatic cancer	1.63e-05	0.000165	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CTNNB1—pancreatic cancer	1.63e-05	0.000165	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	1.61e-05	0.000164	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CG—pancreatic cancer	1.61e-05	0.000163	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—pancreatic cancer	1.59e-05	0.000162	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STK11—pancreatic cancer	1.59e-05	0.000161	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTEN—pancreatic cancer	1.58e-05	0.000161	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	1.58e-05	0.000161	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NFKBIA—pancreatic cancer	1.58e-05	0.000161	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.57e-05	0.000159	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOTCH1—pancreatic cancer	1.57e-05	0.000159	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.55e-05	0.000158	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—pancreatic cancer	1.55e-05	0.000157	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NFKBIA—pancreatic cancer	1.55e-05	0.000157	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HES1—pancreatic cancer	1.55e-05	0.000157	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AKT1—pancreatic cancer	1.55e-05	0.000157	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOTCH1—pancreatic cancer	1.53e-05	0.000156	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CG—pancreatic cancer	1.53e-05	0.000155	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—NRAS—pancreatic cancer	1.53e-05	0.000155	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.52e-05	0.000155	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.52e-05	0.000155	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—pancreatic cancer	1.52e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGF—pancreatic cancer	1.51e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CG—pancreatic cancer	1.5e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—NRAS—pancreatic cancer	1.5e-05	0.000152	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.49e-05	0.000152	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	1.48e-05	0.000151	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGF—pancreatic cancer	1.48e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.48e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SRC—pancreatic cancer	1.47e-05	0.000149	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.43e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—pancreatic cancer	1.43e-05	0.000145	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—pancreatic cancer	1.43e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	1.42e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—pancreatic cancer	1.42e-05	0.000144	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NRAS—pancreatic cancer	1.41e-05	0.000144	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CD—pancreatic cancer	1.41e-05	0.000143	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—pancreatic cancer	1.39e-05	0.000142	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	1.39e-05	0.000141	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.38e-05	0.00014	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.37e-05	0.000139	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—pancreatic cancer	1.37e-05	0.000139	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HES1—pancreatic cancer	1.36e-05	0.000138	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TERT—pancreatic cancer	1.35e-05	0.000138	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CD—pancreatic cancer	1.35e-05	0.000137	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.33e-05	0.000135	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.33e-05	0.000135	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—pancreatic cancer	1.32e-05	0.000135	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CD—pancreatic cancer	1.32e-05	0.000134	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—pancreatic cancer	1.32e-05	0.000134	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—pancreatic cancer	1.32e-05	0.000134	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.32e-05	0.000134	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—pancreatic cancer	1.31e-05	0.000133	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.3e-05	0.000133	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD44—pancreatic cancer	1.3e-05	0.000132	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	1.3e-05	0.000132	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.3e-05	0.000132	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	1.3e-05	0.000132	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	1.29e-05	0.000131	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—pancreatic cancer	1.29e-05	0.000131	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—pancreatic cancer	1.29e-05	0.000131	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—pancreatic cancer	1.26e-05	0.000128	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCG—pancreatic cancer	1.25e-05	0.000127	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	1.25e-05	0.000127	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—pancreatic cancer	1.24e-05	0.000126	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CB—pancreatic cancer	1.23e-05	0.000125	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—pancreatic cancer	1.22e-05	0.000124	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—pancreatic cancer	1.22e-05	0.000124	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—pancreatic cancer	1.21e-05	0.000123	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.21e-05	0.000123	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—pancreatic cancer	1.19e-05	0.000121	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.18e-05	0.00012	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.18e-05	0.00012	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—STK11—pancreatic cancer	1.18e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CB—pancreatic cancer	1.17e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.17e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	1.15e-05	0.000117	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—pancreatic cancer	1.15e-05	0.000117	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.14e-05	0.000116	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	1.14e-05	0.000116	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	1.14e-05	0.000116	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	1.14e-05	0.000115	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC2—pancreatic cancer	1.13e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGF—pancreatic cancer	1.13e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—pancreatic cancer	1.13e-05	0.000114	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	1.13e-05	0.000114	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—pancreatic cancer	1.12e-05	0.000114	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—pancreatic cancer	1.12e-05	0.000114	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—pancreatic cancer	1.11e-05	0.000113	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	1.1e-05	0.000112	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	1.1e-05	0.000111	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—pancreatic cancer	1.09e-05	0.000111	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—pancreatic cancer	1.09e-05	0.000111	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—pancreatic cancer	1.08e-05	0.00011	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—pancreatic cancer	1.08e-05	0.00011	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	1.07e-05	0.000108	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—pancreatic cancer	1.06e-05	0.000108	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	1.06e-05	0.000107	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CB—pancreatic cancer	1.05e-05	0.000107	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—pancreatic cancer	1.05e-05	0.000107	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—pancreatic cancer	1.04e-05	0.000106	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	1.04e-05	0.000106	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CTNNB1—pancreatic cancer	1.04e-05	0.000106	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.03e-05	0.000105	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—pancreatic cancer	1.03e-05	0.000105	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	1.03e-05	0.000104	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.02e-05	0.000104	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—pancreatic cancer	1.02e-05	0.000104	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	1.02e-05	0.000103	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—pancreatic cancer	1.01e-05	0.000103	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TYMS—pancreatic cancer	1.01e-05	0.000103	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	1e-05	0.000102	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1e-05	0.000102	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1e-05	0.000102	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	9.98e-06	0.000101	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.94e-06	0.000101	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	9.92e-06	0.000101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGF—pancreatic cancer	9.91e-06	0.000101	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—pancreatic cancer	9.89e-06	0.0001	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	9.83e-06	9.98e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—pancreatic cancer	9.81e-06	9.97e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	9.68e-06	9.83e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SRC—pancreatic cancer	9.4e-06	9.55e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SRC—pancreatic cancer	9.2e-06	9.35e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	9.15e-06	9.3e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—pancreatic cancer	9.13e-06	9.28e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	9.13e-06	9.28e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—pancreatic cancer	9.09e-06	9.23e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	9.06e-06	9.21e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	9.04e-06	9.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	9.03e-06	9.17e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	8.96e-06	9.1e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	8.87e-06	9.01e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	8.85e-06	8.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	8.81e-06	8.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	8.75e-06	8.89e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.73e-06	8.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	8.63e-06	8.76e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—pancreatic cancer	8.42e-06	8.55e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	8.41e-06	8.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	8.4e-06	8.53e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	8.35e-06	8.48e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—pancreatic cancer	8.25e-06	8.38e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	8.24e-06	8.37e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	8.23e-06	8.36e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—pancreatic cancer	8.22e-06	8.35e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	8.12e-06	8.25e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	8.1e-06	8.22e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	8.07e-06	8.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	8.05e-06	8.17e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	7.93e-06	8.05e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	7.83e-06	7.95e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	7.78e-06	7.9e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	7.76e-06	7.88e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	7.68e-06	7.8e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	7.62e-06	7.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	7.6e-06	7.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	7.56e-06	7.68e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—pancreatic cancer	7.5e-06	7.62e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—pancreatic cancer	7.42e-06	7.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	7.38e-06	7.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	7.37e-06	7.49e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	7.33e-06	7.45e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—pancreatic cancer	7.16e-06	7.27e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	7.15e-06	7.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	7.13e-06	7.24e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—pancreatic cancer	7.06e-06	7.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SRC—pancreatic cancer	7.01e-06	7.12e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	7e-06	7.11e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	6.92e-06	7.03e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—pancreatic cancer	6.92e-06	7.02e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—pancreatic cancer	6.88e-06	6.98e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	6.83e-06	6.93e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	6.81e-06	6.92e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—pancreatic cancer	6.77e-06	6.88e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	6.76e-06	6.87e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	6.74e-06	6.85e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—pancreatic cancer	6.68e-06	6.78e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—pancreatic cancer	6.64e-06	6.74e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	6.61e-06	6.72e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—pancreatic cancer	6.61e-06	6.72e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.52e-06	6.63e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	6.48e-06	6.58e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	6.47e-06	6.58e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—pancreatic cancer	6.41e-06	6.51e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—pancreatic cancer	6.28e-06	6.38e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	6.27e-06	6.36e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SRC—pancreatic cancer	6.15e-06	6.25e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	6.14e-06	6.24e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—pancreatic cancer	6.13e-06	6.22e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	5.99e-06	6.09e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—pancreatic cancer	5.94e-06	6.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NRAS—pancreatic cancer	5.92e-06	6.01e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	5.84e-06	5.93e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	5.8e-06	5.9e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	5.72e-06	5.81e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.69e-06	5.78e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—pancreatic cancer	5.66e-06	5.74e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.63e-06	5.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—pancreatic cancer	5.52e-06	5.6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	5.5e-06	5.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—pancreatic cancer	5.39e-06	5.48e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	5.33e-06	5.42e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—pancreatic cancer	5.24e-06	5.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—pancreatic cancer	5.16e-06	5.24e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—pancreatic cancer	5.1e-06	5.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	4.93e-06	5.01e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—pancreatic cancer	4.91e-06	4.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	4.68e-06	4.76e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—pancreatic cancer	4.53e-06	4.6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	4.36e-06	4.42e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—pancreatic cancer	4.33e-06	4.4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—pancreatic cancer	3.82e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.47e-06	3.52e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—pancreatic cancer	2.83e-06	2.88e-05	CbGpPWpGaD
